Anti Hiv
May 04, 2012 at 13:45 | Source: CNBC-TV18
Oct 28, 2011 at 19:37 | Source: PTI
Aug 24, 2011 at 14:11 | Source: Reuters
Jul 07, 2011 at 19:29 | Source: Reuters
May 27, 2011 at 16:12 | Source: PTI
Apr 04, 2011 at 12:50 | Source: CNBC-TV18
News across the web »
May 04, 2012 at 18:50 | Source: FirstPost
May 04, 2012 at 15:16 | Source: FirstPost
Mar 28, 2012 at 15:09 | Source: Business Today
Feb 16, 2012 at 22:36 | Source: Forbes
Interact & exchange stock tips & market info »
Related News »
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the ...
May 15, 2012 at 20:47 | Source: medicalxpress.com
As follow-up to MTN-007, researchers are now planning a Phase II, multi-site trial called MTN-017 that will involve 186 men who have sex with men, and transgender women at clinical sites in Peru, South Africa, Thailand, and the U.S. Participants ...
May 17, 2012 at 05:57 | Source: News-Medical.Net
On 10 May, the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) held a marathon debate about whether an anti-HIV drug on the market as a treatment should receive approval as a preventive for uninfected people. For more than ...
May 17, 2012 at 18:22 | Source: Science Now
Tenofovir, the anti-HIV drug, is safe to use during pregnancy according to a new study published in PloS Medicine. The researchers, led by Diana Gibb from the MRC Clinical Trials Unit in London, UK, found that the drug does not increase the risk ...
May 15, 2012 at 20:55 | Source: Medical News Today
According to a study published by the journal International AIDS Society a part of potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced ...
May 28, 2012 at 09:55 | Source: Med India
New Delhi: Aurobindo Pharma today said it has received final approval from the US health regulator for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The company has received final ...
May 25, 2012 at 04:51 | Source: zeenews.india.com
The microbicides that have proven to be partially effective to date contain an anti-HIV drug known as Tenofovir. PrEP is an approach that involves the use of oral anti-HIV drugs taken by uninfected individuals to prevent HIV infection if exposed to the virus.
May 17, 2012 at 18:36 | Source: PR Newswire
Philadelphia, Pa. (May 22, 2012) – Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system ...
May 22, 2012 at 16:14 | Source: EurekAlert
The FDA's Antiviral Drugs Advisory committee voted 19-3 Thursday that an anti-HIV combination pill should be approved to prevent HIV infection in healthy people. The combination of emtricitabine and tenofovir (Truvada), made by Gilead Sciences ...
May 12, 2012 at 14:53 | Source: MedPage Today
About GeoVax's Technology GeoVax's unique two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax's DNA and MVA ...
May 28, 2012 at 13:08 | Source: Yahoo Finance